Subsequent Events	9 Months Ended
Sep. 30, 2025
Subsequent Events
Subsequent Events	15. Subsequent Events Issuance of Common Stock From October 1, 2025, to November 14, 2025, the Company issued an aggregate of 36,114 shares of common stock under the December 2021 ATM Agreement for total net proceeds of approximately $81,000. Note Purchase Agreement On November 12, 2025, Jaguar Health, Inc. (the “Company”) entered into a note purchase agreement with Streeterville, pursuant to which the Company issued and sold to Streeterville a secured promissory note in the original principal amount of $10,810,000 (the “Note”). The Note carries an original issue discount of $800,000 and the Company agreed to pay $10,000 to Streeterville to cover its legal fees, accounting costs, due diligence, monitoring and other transaction costs, both of which were included in the original principal balance of this Note. On the closing date, Streeterville paid $2.0 million to the Company and $8.0 million was sent to an account at Lakeside Bank owned by the Company’s newly formed wholly-owned subsidiary, JAGX Holdings, LLC, a Utah limited liability company (“JAGX Sub”), to be held pursuant to a Deposit Account Control Agreement entered into among JAGX Sub, Lender, and Lakeside Bank. Interest under the Note accrues at a rate of 8.00% per annum. The unpaid amount of the Note, any interest, fees, charges and late fees are due 36 months following the date of issuance. The Company may prepay all or any portion of the outstanding balance of the Note after the date of issuance.

Subsequent Events

9 Months Ended

Sep. 30, 2025

15. Subsequent Events

Issuance of Common Stock

From October 1, 2025, to November 14, 2025, the Company issued an aggregate of 36,114 shares of common stock under the December 2021 ATM Agreement for total net proceeds of approximately $81,000.

Note Purchase Agreement

On November 12, 2025, Jaguar Health, Inc. (the “Company”) entered into a note purchase agreement with Streeterville, pursuant to which the Company issued and sold to Streeterville a secured promissory note in the original principal amount of $10,810,000 (the “Note”). The Note carries an original issue discount of $800,000 and the Company agreed to pay $10,000 to Streeterville to cover its legal fees, accounting costs, due diligence, monitoring and other transaction costs, both of which were included in the original principal balance of this Note. On the closing date, Streeterville paid $2.0 million to the Company and $8.0 million was sent to an account at Lakeside Bank owned by the Company’s newly formed wholly-owned subsidiary, JAGX Holdings, LLC, a Utah limited liability company (“JAGX Sub”), to be held pursuant to a Deposit Account Control Agreement entered into among JAGX Sub, Lender, and Lakeside Bank.

Interest under the Note accrues at a rate of 8.00% per annum. The unpaid amount of the Note, any interest, fees, charges and late fees are due 36 months following the date of issuance. The Company may prepay all or any portion of the outstanding balance of the Note after the date of issuance.